Combining epigenetic therapy and immunotherapeutic avenues for chronic HBV infection
Epigenomics · 04.05.2026 · 18 (5) · 531-533
DOI: 10.1080/17501911.2026.2664392 ↗Kurz gefasst
Editorial in der Zeitschrift Epigenomics, online erschienen am 24.04.2026. Verfasst von Yin-Han Chou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: German Research Foundation, German Center for Infection Research, Hannover Biomedical Research School.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
- Joint Venture Between Helmholtz-Centre for Infection Research and Hannover Medical School, Hannover, Germany.
- German Center for Infection Research (DZIF), partner site Hannover-Braunschweig, Hannover, Germany.
- Cluster of Excellence RESIST (EXC2155), Hannover Medical School, Hannover, Germany.
ORCID-Profile: Yin-Han Chou, Markus Cornberg
Förderung
- German Research Foundation
- German Center for Infection Research
- Hannover Biomedical Research School
- Center for Infection Biology
Zitieren
APA
Chou, Y. H., & Cornberg, M. (2026). Combining epigenetic therapy and immunotherapeutic avenues for chronic HBV infection. Epigenomics, 18(5), 531-533. https://doi.org/10.1080/17501911.2026.2664392
Vancouver
Chou YH, Cornberg M. Combining epigenetic therapy and immunotherapeutic avenues for chronic HBV infection. Epigenomics. 2026;18(5):531-533. doi:10.1080/17501911.2026.2664392
BibTeX
@article{Chou2026,
author = {Chou, Yin-Han and Cornberg, Markus},
title = {Combining epigenetic therapy and immunotherapeutic avenues for chronic HBV infection},
journal = {Epigenomics},
year = {2026},
volume = {18},
number = {5},
pages = {531--533},
doi = {10.1080/17501911.2026.2664392}
}
EUVIMED